First and foremost, Habre recommends staying indoors as much as possible and keeping your windows closed. While the air may ...

First and foremost, Habre recommends staying indoors as much as possible and keeping your windows closed. While the air may ...

By not only trapping smoke and viruses, but destroying them too, these could be some of the most effective masks you can buy ...

Share on Pinterest N95 face masks offer the best protection from lung damage from wildfire smoke but KN95 masks are also effective. JOSH EDELSON/AFP via Getty Images As wildfires decimate ...

While the FDA initially authorized many different kinds of KN95 masks for emergency use during the pandemic, Lang points out that it later retracted its approval of several brands that failed to m ...

The Andhra Pradesh cabinet approves two engineering projects worth Rs 2,723 crore for Amaravati, including a green ammonia manufacturing facility and South India's first integrated energy project.

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the ...

One-time special package up to Rs 3,850 crore is approved for DAP fertiliser,” information and broadcasting minister Ashwini Vaishnaw said in a press briefing. He pointed out that the global ...

Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...

Ryoncil, the first mesenchymal stromal cell therapy, showed a 70% overall response rate in pediatric steroid-refractory acute GVHD, with a median DOR of 54 days. The FDA approved several drugs in ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...